EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents
- PMID: 26851656
- DOI: 10.1016/j.cmi.2016.01.017
EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents
Abstract
The Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) has determined breakpoints for isavuconazole and Aspergillus and for itraconazole and Candida spp., released a new document summarizing existing and new minimum inhibitory concentration ranges for quality control strains and revised the method documents for yeast and mould susceptibility testing. This technical note is based on the EUCAST isavuconazole and itraconazole rationale documents, version 1.0 of the routine and extended internal quality control for antifungal susceptibility testing as recommended by EUCAST, and the E.Def 7.3, E.Def 9.2 and E.Def 9.3 method documents (http://www.eucast.org).
Keywords: Antifungal susceptibility testing; QC MIC ranges; breakpoints; isavuconazole; itraconazole.
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole.Clin Microbiol Infect. 2012 Jul;18(7):E248-50. doi: 10.1111/j.1469-0691.2012.03890.x. Epub 2012 Apr 30. Clin Microbiol Infect. 2012. PMID: 22540149
-
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).Clin Microbiol Infect. 2020 Nov;26(11):1464-1472. doi: 10.1016/j.cmi.2020.06.007. Epub 2020 Jun 17. Clin Microbiol Infect. 2020. PMID: 32562861 Review.
-
Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).Clin Microbiol Infect. 2007 Oct;13(10):1018-22. doi: 10.1111/j.1469-0691.2007.01790.x. Epub 2007 Aug 13. Clin Microbiol Infect. 2007. PMID: 17697001
-
EUCAST technical note on Amphotericin B.Clin Microbiol Infect. 2011 Dec;17(12):E27-9. doi: 10.1111/j.1469-0691.2011.03644.x. Epub 2011 Oct 19. Clin Microbiol Infect. 2011. PMID: 22011310
-
How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton.Clin Microbiol Infect. 2021 Jan;27(1):55-60. doi: 10.1016/j.cmi.2020.08.042. Epub 2020 Sep 8. Clin Microbiol Infect. 2021. PMID: 32916260 Review.
Cited by
-
EUCAST Reference Testing of Rezafungin Susceptibility and Impact of Choice of Plastic Plates.Antimicrob Agents Chemother. 2019 Aug 23;63(9):e00659-19. doi: 10.1128/AAC.00659-19. Print 2019 Sep. Antimicrob Agents Chemother. 2019. PMID: 31285230 Free PMC article.
-
Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp.Antimicrob Agents Chemother. 2020 Mar 24;64(4):e01921-19. doi: 10.1128/AAC.01921-19. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 31988099 Free PMC article.
-
Adaptation of the emerging pathogenic yeast Candida auris to high caspofungin concentrations correlates with cell wall changes.Virulence. 2021 Dec;12(1):1400-1417. doi: 10.1080/21505594.2021.1927609. Virulence. 2021. PMID: 34180774 Free PMC article.
-
Invasive Candida parapsilosis Bloodstream Infections in Children: The Antifungal Susceptibility, Clinical Characteristics and Impacts on Outcomes.Microorganisms. 2023 Apr 28;11(5):1149. doi: 10.3390/microorganisms11051149. Microorganisms. 2023. PMID: 37317123 Free PMC article.
-
Azole-Resistant Aspergillus fumigatus Among Danish Cystic Fibrosis Patients: Increasing Prevalence and Dominance of TR34/L98H.Front Microbiol. 2020 Aug 13;11:1850. doi: 10.3389/fmicb.2020.01850. eCollection 2020. Front Microbiol. 2020. PMID: 32903400 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous